Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120
Nina D. Russell(New York Blood Center), Lawrence Corey(Fred Hutch Cancer Center), Barney S. Graham(National Institutes of Health), Susan Buchbinder(University of California, San Francisco), Kent J. Weinhold(Duke Medical Center), Lynn Baglyos(New York Blood Center), Georgia D. Tomaras(National Institutes of Health), Guido Ferrari(Duke University), Clayton Harro(Johns Hopkins University), Steve Self(Cancer Research Center), Beryl A. Koblin(New York Blood Center), Mark J. Mulligan(New York University), Sharon E. Frey(St. Louis VA Medical Center), M. Juliana McElrath(Fred Hutch Cancer Center), Lindsey R. Baden(Brigham and Women's Hospital), Helen Horton(New York Blood Center), Michael C. Keefer(University of Rochester Medical Center), Sanjay Gurunathan(GTx (United States)), William A. Blattner(Unknown), David C. Montefiori(Duke University)
JAIDS Journal of Acquired Immune Deficiency Syndromes
November 22, 2006
Cited by 104
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k